Badanie wpływu kariprazyny na funkcje poznawcze u pacjentów ze schizofrenią wymagających zmiany leczenia przeciwpsychotycznego

Schizophrenia is a mental health condition that affects how a person thinks, feels, and behaves. This study focuses on patients with schizophrenia who need changes in their current oral antipsychotic treatment. The study will use a medication called cariprazine, which is available in the form of hard capsules known as Reagila. The main goal of the study is to see how cariprazine affects thinking and understanding in patients with schizophrenia.

Participants in the study will start taking cariprazine, and their cognitive functioning, which refers to mental processes like memory and problem-solving, will be monitored. The study will observe changes over a period of time to understand how the medication impacts these mental processes. The study will also look at other aspects of the patients' health and well-being during this period.

The study is designed to provide insights into how cariprazine can help improve cognitive functioning in people with schizophrenia. This information could be useful for adjusting treatment plans for patients who need changes in their current medication. The study will last for several months, allowing researchers to gather comprehensive data on the effects of cariprazine.